Khasigo DX 4 Syrup 100ml

Khasigo DX 4 Syrup 100ml contains two active ingredients: Chlorpheniramine Maleate and Dextromethorphan Hydrobromide, each contributing a specific therapeutic action in cough and cold management.

Chlorpheniramine Maleate is a first-generation antihistamine that blocks histamine H1 receptors. Histamine is the chemical messenger responsible for sneezing, runny nose, watery eyes, itching, and excess mucus during allergic reactions. By preventing histamine from binding to its receptors, Chlorpheniramine helps dry nasal secretions, reduce irritation, and ease allergy-related discomfort. Because it can act on the brain, it may also cause mild drowsiness, which sometimes helps patients rest more comfortably when symptoms interfere with sleep.

Dextromethorphan Hydrobromide complements this action as a non-opioid cough suppressant. It acts centrally by elevating the threshold for coughing in the medulla oblongata of the brain. Unlike productive coughs that help clear the lungs, the dry, hacking cough associated with many viral infections can irritate the airway further and interfere with rest. Dextromethorphan interrupts this reflex, providing the respiratory system with the necessary reprieve to facilitate healing.

Together, these active ingredients are absorbed rapidly into the systemic circulation, typically providing symptomatic relief within 30 minutes of administration. Chlorpheniramine is metabolised in the liver and excreted through the kidneys, while Dextromethorphan is also metabolised in the liver, and eliminated in urine. When taken as directed, Khasigo DX 4 Syrup 100ml helps reduce coughing episodes, ease allergy-driven nasal and eye symptoms, and support more comfortable breathing and rest during short-term respiratory illness.

Cough Associated with Upper Respiratory Infections

Symptomatic relief of non-productive (dry) cough caused by the common cold, flu, or upper respiratory tract infections.

Allergic Rhinitis with Cough

Management of concurrent allergic symptoms and cough in patients with seasonal or perennial allergic rhinitis.

Post-nasal Drip-Induced Cough

Relief of cough triggered by post-nasal drip associated with allergic or infective rhinitis, where both antihistamine and antitussive coverage is beneficial.

Common Cold Symptoms

Multi-symptom relief including sneezing, runny nose, nasal itching, watery eyes, and dry irritating cough.

• Dual-Symptom Relief: Addresses both allergic upper respiratory symptoms and cough simultaneously, reducing the need for separate medicines.

• Reduces Allergy-Related Irritation: Chlorpheniramine helps relieve sneezing, runny nose, watery eyes, and throat irritation caused by histamine release.

• Mild Sedative Benefit: The mild sedative property of Chlorpheniramine may provide additional comfort for patients whose symptoms disrupt sleep at night.

• Non-Opioid Cough Suppression: Dextromethorphan provides effective cough relief without the respiratory depression or dependence risk associated with opioid antitussives at recommended doses.

Khasigo DX 4 Syrup 100ml may cause side effects, although not everyone will experience them. Most reactions are mild and temporary, but some can be more significant and require medical attention.

More Common Side Effects

• Drowsiness or sedation, primarily due to Chlorpheniramine

• Dry mouth, nose, or throat

• Dizziness or light-headedness

• Nausea or gastric discomfort

• Headache

Less Common Side Effects

• Constipation

• Blurred vision

• Urinary retention or difficulty urinating, particularly in older men or those with prostate enlargement

• Insomnia or paradoxical excitability, particularly in children

• Mild palpitations

Serious Side Effects (Seek Medical Help Immediately)

• Severe allergic reactions: angioedema (swelling of the face, lips, tongue, or throat), urticaria (hives), or anaphylaxis

• Serotonin syndrome (particularly with concurrent serotonergic medicines): agitation, confusion, rapid heartbeat, sweating, and muscle stiffness or twitching

• Severe CNS depression: extreme drowsiness, loss of coordination, or loss of consciousness, particularly in cases of misuse or overdose

• Severe skin reactions: blistering, widespread skin peeling, or mucosal involvement (rare)

• Respiratory depression: though uncommon at therapeutic doses, may occur in overdose or in very young children

Take Khasigo DX 4 Syrup 100ml only as directed, never more than prescribed, and check with your doctor before combining it with other medicines. If your symptoms don’t improve, seek medical advice rather than continuing on your own.

• Chlorpheniramine Maleate is a first-generation antihistamine. It works by blocking histamine H1 receptors, which are responsible for allergy-related symptoms such as sneezing, runny nose, watery eyes, and nasal itching. By preventing histamine from binding to these receptors, it reduces the body’s allergic response. Because it can cross into the brain, it may also cause drowsiness, which sometimes helps patients rest when symptoms interfere with sleep.

• Dextromethorphan is a centrally acting cough suppressant. It works directly on the cough centre in the brainstem (medulla oblongata), raising the threshold for cough stimulation. This means the urge to cough becomes less frequent and less intense, while normal breathing remains unaffected. Unlike opioid-based cough medicines, Dextromethorphan does not usually cause respiratory depression or dependence when taken at recommended doses, though misuse at high doses can be harmful.

• Short-Term Use Only: Khasigo DX 4 Syrup 100ml is intended for temporary relief of cough and allergy-related symptoms. If your cough persists or worsens, it may signal an underlying condition such as asthma, infection, or postnasal drip that requires medical evaluation.

• Do Not Exceed the Recommended Dose: Taking more than prescribed, especially of Dextromethorphan, can cause serious effects on the brain, including hallucinations, dissociation, and loss of coordination. Always follow the exact dose advised by your doctor.

• Use with Caution in the Elderly: Older adults are more sensitive to Chlorpheniramine’s sedative and anticholinergic effects, which may lead to drowsiness, dry mouth, constipation, or difficulty urinating.

• Avoid in Certain Pre-existing Conditions: Patients with closed-angle glaucoma, urinary retention, or prostate enlargement should only use this medicine under strict medical supervision, as Chlorpheniramine can worsen these conditions.

• Inform Your Doctor of All Medicines: Dextromethorphan can interact with antidepressants and other serotonergic drugs, increasing the risk of a serious reaction called serotonin syndrome. Always share your complete medication list with your healthcare provider before starting treatment.

• Food (Mild): Khasigo DX 4 Syrup 100ml may be taken with or without food. Taking it with food may help reduce the risk of gastric discomfort.

• Alcohol (Severe): Alcohol significantly potentiates the CNS depressant effects of both active ingredients, increasing the risk of excessive sedation, dizziness, impaired coordination, and respiratory depression.

• Grapefruit Juice (Mild): Grapefruit juice may inhibit CYP3A4-mediated metabolism of Dextromethorphan in some individuals, potentially increasing its plasma levels and the risk of side effects. Excessive consumption is best avoided during treatment.

• Caffeine (Mild): Caffeine may partially counteract the sedative effects of Chlorpheniramine but does not alter the antitussive activity of Dextromethorphan.

• Monoamine Oxidase Inhibitors or MAOIs (Severe): Concurrent use of Dextromethorphan with MAOIs is strictly contraindicated and may cause serotonin syndrome, a potentially life-threatening condition characterised by agitation, hyperthermia, muscle rigidity, and cardiovascular instability. A minimum 14-day washout period after stopping an MAOI is required before starting Khasigo DX 4 Syrup 100ml.

• Selective Serotonin Reuptake Inhibitors or SSRIs (Moderate): Concurrent use may increase the risk of serotonin syndrome. Fluoxetine and paroxetine additionally inhibit CYP2D6, reducing the metabolism of Dextromethorphan and raising its plasma levels. Use with caution and medical supervision.

• Other CNS Depressants (Moderate): Sedating antihistamines, benzodiazepines, opioids, and sleep medicines may significantly intensify the CNS depressant effects of both active ingredients, increasing the risk of excessive sedation and respiratory depression.

• CYP2D6 Inhibitors (Moderate): Medicines that inhibit CYP2D6, including fluoxetine, paroxetine, bupropion, and quinidine, may reduce the hepatic metabolism of Dextromethorphan, leading to elevated plasma levels and an increased risk of CNS adverse effects.

• Anticholinergic Medicines (Moderate): Concurrent use with other anticholinergic agents such as certain antispasmodics, bladder medicines, or tricyclic antidepressants may compound the anticholinergic effects of Chlorpheniramine, including dry mouth, urinary retention, constipation, and blurred vision.

• Tricyclic Antidepressants or TCAs (Moderate): May enhance both the anticholinergic effects of Chlorpheniramine and the serotonergic activity of Dextromethorphan, increasing the risk of adverse cardiovascular and CNS effects.

• Asthma or Chronic Obstructive Pulmonary Disease or COPD (Severe): Cough suppression with Dextromethorphan may mask important respiratory symptoms and impair mucus clearance in patients with chronic airway disease. Use only under medical supervision in these patients.

• Closed-Angle Glaucoma (Moderate): Chlorpheniramine's anticholinergic properties may increase intraocular pressure. This combination should be avoided or used with extreme caution in patients with closed-angle glaucoma.

• Prostatic Hyperplasia or Urinary Retention (Moderate): Chlorpheniramine may worsen urinary retention due to its anticholinergic effects. Use with caution in older men with known prostatic enlargement.

• Hepatic Impairment (Moderate): Both components rely on hepatic metabolism. Significant liver disease may impair clearance and increase the risk of drug accumulation and adverse effects.

• Seizure Disorders (Moderate): High doses of Dextromethorphan may lower the seizure threshold. Use with caution and under medical supervision in patients with known epilepsy.

• Depression or Psychiatric Conditions (Moderate): Dextromethorphan's CNS activity and potential for misuse at high doses require careful consideration in patients with psychiatric conditions. Medical assessment is essential before prescribing.

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular schedule. Never take two doses at the same time. Since Khasigo DX 4 Syrup 100ml is typically used for short-term symptomatic relief, missing a dose may simply mean a temporary return of symptoms. If symptoms are difficult to manage, consult your healthcare provider.